Seminars in Ultrasound, CT and MRI
Volume 28, Issue 2 , Pages 101-108, April 2007

Screening for Blunt Cerebrovascular Injuries: The Essential Role of Computed Tomography Angiography

  • Dirk Stengel, MD, PhD, MSc

      Affiliations

    • Center for Clinical Research and Department of Trauma and Orthopaedic Surgery, Berlin, Germany.
    • Corresponding Author InformationAddress reprint requests to Dirk Stengel, MD, PhD, MSc, Center for Clinical Research, Unfallkrankenhaus Berlin Trauma Center, Warener Str 7, 12683 Berlin, Germany.
  • ,
  • Grit Rademacher, MD

      Affiliations

    • Institute of Radiology, Unfallkrankenhaus Berlin Trauma Center, Berlin, Germany.
  • ,
  • Beate Hanson, MD, MPH

      Affiliations

    • AO Clinical Investigation and Documentation, Zurich, Switzerland.
  • ,
  • Axel Ekkernkamp, MD, PhD

      Affiliations

    • Center for Clinical Research and Department of Trauma and Orthopaedic Surgery, Berlin, Germany.
  • ,
  • Sven Mutze, MD, PhD

      Affiliations

    • Institute of Radiology, Unfallkrankenhaus Berlin Trauma Center, Berlin, Germany.

The implementation of aggressive diagnostics refuted the thesis that blunt cerebrovascular injuries (BCVI) are rare events. Given the estimates from recent studies, the prevalence may be as high as 1 per 100 among blunt multiple trauma patients. The morbidity and mortality of unrecognized and untreated BCVI is exceptionally high and warrants distinct efforts to detect these injuries during the primary trauma survey. The primary goal is to detect BCVI before neurological symptoms occur, and to introduce anticoagulation or antiplatelet therapy as appropriate. Index injuries such as cervical spine fractures increase the prior probability of disease, but are not helpful in ruling BCVI out. Computed tomography angiography (CTA) may represent the screening tool of choice, although there is still limited evidence about its accuracy. Pooled data from six studies (1368 patients) published between 2002 and 2006 suggest a sensitivity of 79% and a specificity of 97% in the trauma setting. In the two largest investigations, no false negative results were observed. Further research is needed to determine the efficacy of CTA for disclosing BCVI, and to evaluate the potential benefits to patients.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0887-2171(07)00017-0

doi:10.1053/j.sult.2007.01.009

Seminars in Ultrasound, CT and MRI
Volume 28, Issue 2 , Pages 101-108, April 2007